Skip to main content

Articles

Page 11 of 59

  1. Galectins are β-galactoside-binding proteins that bind and crosslink molecules via their sugar moieties, forming signaling and adhesion networks involved in cellular communication, differentiation, migration, ...

    Authors: Adel Abo Mansour, Franziska Krautter, Zhaogong Zhi, Asif Jilani Iqbal and Carlota Recio
    Citation: Cardiovascular Diabetology 2022 21:253
  2. Although type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) share many common pathological and physiological characteristics, there are few studies assessing the predictive capacity of novel bio...

    Authors: Yanhong Chen, Yu Fu, Shixin Wang, Pengsheng Chen, Yunfeng Pei, Jiao Zhang, Rui Zhang, Guoping Niu, Feng Gu and Xiaoli Li
    Citation: Cardiovascular Diabetology 2022 21:252
  3. It is unclear whether mental disorders are an independent risk factor for atrial fibrillation (AF) in patients with diabetes. We aimed to investigate whether patients with diabetes who have mental disorders ha...

    Authors: Nan Young Bae, So-Ryoung Lee, Eue-Keun Choi, Hyun Jin Ahn, Hyo-Jeong Ahn, Soonil Kwon, Kyung-Do Han, Kyu-Na Lee, Seil Oh and Gregory Y. H. Lip
    Citation: Cardiovascular Diabetology 2022 21:251
  4. Triglyceride-glucose (TyG) index is a simple and reliable surrogate marker of insulin resistance. Elevated TyG index was related to stroke recurrence. This study aimed to explore the associations between TyG i...

    Authors: Li Wu, Jinmao Zhu, Chenghao Li, Juehua Zhu, Zheng Dai and Yongjun Jiang
    Citation: Cardiovascular Diabetology 2022 21:250
  5. Pleiotropic effects have been implicated in clinical benefits of ticagrelor compared to thienopyridine P2Y12 antagonists. There are conflicting data regarding effects of ticagrelor vs. thienopyridine P2Y12 blocke...

    Authors: Bernadeta Chyrchel, Olga Kruszelnicka and Andrzej Surdacki
    Citation: Cardiovascular Diabetology 2022 21:249
  6. The reno-protective effect of second-line treatments in type 2 diabetes has been assessed by clinical trials but generalizability to routine clinical practice is still uncertain. We aimed to assess the effecti...

    Authors: Sukanya Siriyotha, Thitiya Lukkunaprasit, Panu Looareesuwan, Hataikarn Nimitphong, Gareth J. McKay, John Attia and Ammarin Thakkinstian
    Citation: Cardiovascular Diabetology 2022 21:248
  7. Cardiovascular risk and body-weight management are both emerging challenges of type 1 diabetes care. We evaluated the association between intraindividual variability of body-weight and risk of cardiovascular e...

    Authors: Iulia Petria, Samuel Albuquerque, Gaël Varoquaux, Jill-Jênn Vie, Nicolas Venteclef, Kamel Mohammedi, Ronan Roussel, Marion Camoin, Gianluca Perseghin, Gilberto Velho and Louis Potier
    Citation: Cardiovascular Diabetology 2022 21:247
  8. Diabetes Mellitus (DM) affects a third of patients with symptomatic severe aortic valve stenosis undergoing transcatheter aortic valve implantation (TAVI). DM is a well-known risk factor for cardiac surgery, b...

    Authors: Astrid C. van Nieuwkerk, Raquel B. Santos, Roberto Blanco Mata, Didier Tchétché, Fabio S. de Brito Jr, Marco Barbanti, Ran Kornowski, Azeem Latib, Augusto D’Onofrio, Flavio Ribichini, Jan Baan, Juan Oteo-Dominguez, Nicolas Dumonteil, Alexandre Abizaid, Samantha Sartori, Paola D’Errigo…
    Citation: Cardiovascular Diabetology 2022 21:246
  9. Hypertriglyceridemia is an important feature of dyslipidemia in type 1 and type 2 diabetic patients and associated with the development of atherosclerotic cardiovascular disease. Recently, variability of lipid...

    Authors: Sung Min Koh, Se Hwa Chung, Yun Jin Yum, Se Jun Park, Hyung Joon Joo, Yong-Hyun Kim and Eung Ju Kim
    Citation: Cardiovascular Diabetology 2022 21:245
  10. Carotid plaque and triglyceride-glucose (TyG) index are associated with insulin resistance. However, a highly debated question is whether there is an association between the TyG index and carotid plaque incide...

    Authors: Yichi Zhang, Zhuchao Wu, Xiaona Li, Jingkai Wei, Qun Zhang and Jianming Wang
    Citation: Cardiovascular Diabetology 2022 21:244
  11. The effect of diabetes mellitus (DM) on the long-term outcomes of coronary artery bypass graft (CABG) remained debatable and various strategies exist for CABG; hence, clarifying the effects of DM on CABG outco...

    Authors: Ilkun Park, Kuk Bin Choi, Joong Hyun Ahn, Wook Sung Kim, Young Tak Lee and Dong Seop Jeong
    Citation: Cardiovascular Diabetology 2022 21:243
  12. Several randomized controlled trials have demonstrated the benefits of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on ischemic stroke in patients with diabetes. In this review, we summarize and discus...

    Authors: Bruno Vergès, Victor Aboyans, Denis Angoulvant, Pierre Boutouyrie, Bertrand Cariou, Fabien Hyafil, Kamel Mohammedi and Pierre Amarenco
    Citation: Cardiovascular Diabetology 2022 21:242
  13. Circulating fibrinogen-to-albumin ratio (FAR) has been proposed as a novel inflammatory biomarker and a cardiovascular disease risk predictor. However, its prognostic value in patients with acute decompensated...

    Authors: Rong Huang, Qing Dai, Lei Chang, Ziyan Wang, Jianzhou Chen, Rong Gu, Hongyan Zheng, Lei Hu, Biao Xu and Lian Wang
    Citation: Cardiovascular Diabetology 2022 21:241
  14. Nonalcoholic fatty liver disease is associated with an increased cardiovascular disease (CVD) risk, although the exact mechanism(s) are less clear. Moreover, the relationship between newly redefined metabolic-...

    Authors: Karolina Drożdż, Katarzyna Nabrdalik, Hanna Kwiendacz, Mirela Hendel, Anna Olejarz, Andrzej Tomasik, Wojciech Bartman, Jakub Nalepa, Janusz Gumprecht and Gregory Y. H. Lip
    Citation: Cardiovascular Diabetology 2022 21:240
  15. The baseline coronary plaque burden is the most important factor for rapid plaque progression (RPP) in the coronary artery. However, data on the independent predictors of RPP in the absence of a baseline coron...

    Authors: Ki-Bum Won, Byoung Kwon Lee, Fay Y. Lin, Martin Hadamitzky, Yong-Jin Kim, Ji Min Sung, Edoardo Conte, Daniele Andreini, Gianluca Pontone, Matthew J. Budoff, Ilan Gottlieb, Eun Ju Chun, Filippo Cademartiri, Erica Maffei, Hugo Marques, Pedro de Araújo Gonçalves…
    Citation: Cardiovascular Diabetology 2022 21:239
  16. Previous studies reported that there was right ventricular (RV) systolic dysfunction in patients with hypertension. The aim of this study was to evaluate the impact of type 2 diabetes mellitus (T2DM) on RV sys...

    Authors: Xue-Ming Li, Wei-Feng Yan, Li Jiang, Ke Shi, Yan Ren, Pei-Lun Han, Li-Qing Peng, Ying-Kun Guo and Zhi-Gang Yang
    Citation: Cardiovascular Diabetology 2022 21:238
  17. Optimal treatment strategies for patients with heart failure with preserved ejection fraction (HFpEF) remain uncertain. The goal of this study was to compare the treatment effects of different therapeutic agen...

    Authors: Yaowang Lin, Zhigang Cai, Jie Yuan, Huadong Liu, Xinli Pang, Qiuling Chen, Xinzheng Tang, Qingshan Geng and Shaohong Dong
    Citation: Cardiovascular Diabetology 2022 21:237
  18. Even though hyperglycemia is a well-known cardiovascular risk factor, the absolute risk of cardiovascular events varies to a great extent within each glycemic category. The aim of this study is to evaluate whe...

    Authors: Stefano Ciardullo, Federico Rea, Rosa Cannistraci, Emanuele Muraca, Silvia Perra, Francesca Zerbini, Andrea Mortara and Gianluca Perseghin
    Citation: Cardiovascular Diabetology 2022 21:236
  19. Nephropathy in Diabetes type 2 (NID-2) study is an open-label cluster randomized clinical trial that demonstrated that multifactorial intensive treatment reduces Major Adverse Cardiac Events (MACEs) and overal...

    Authors: Ferdinando Carlo Sasso, Vittorio Simeon, Raffaele Galiero, Alfredo Caturano, Luca De Nicola, Paolo Chiodini, Luca Rinaldi, Teresa Salvatore, Miriam Lettieri, Riccardo Nevola, Celestino Sardu, Giovanni Docimo, Giuseppe Loffredo, Raffaele Marfella, Luigi Elio Adinolfi and Roberto Minutolo
    Citation: Cardiovascular Diabetology 2022 21:235
  20. Bioactive lipids play an important role in insulin secretion and sensitivity, contributing to the pathophysiology of type 2 diabetes (T2D). This study aimed to identify novel lipid species associated with inci...

    Authors: Junda Zhong, Chloe Y. Y. Cheung, Xiuli Su, Chi-Ho Lee, Yi Ru, Carol H. Y. Fong, Yan Liu, Cynthia K. Y. Cheung, Karen S. L. Lam, Zongwei Cai and Aimin Xu
    Citation: Cardiovascular Diabetology 2022 21:234
  21. The prognostic value of common and frequently associated diabetic microvascular complications (MVC), namely chronic kidney disease (CKD), cardiac autonomic neuropathy (CAN), peripheral neuropathy (DPN), and re...

    Authors: Luca Sacchetta, Martina Chiriacò, Lorenzo Nesti, Simone Leonetti, Giovanna Forotti, Andrea Natali, Anna Solini and Domenico Tricò
    Citation: Cardiovascular Diabetology 2022 21:233
  22. To evaluate the cardiovascular and renal benefits of finerenone, sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagonlike peptide-1 receptor agonists (GLP-1 RA) in patients with Type 2 Diabetes Mell...

    Authors: Yaofu Zhang, Li Jiang, Junheng Wang, Tongxin Wang, Chieh Chien, Weijun Huang, Xiaozhe Fu, Yonghua Xiao, Qiang Fu, Shidong Wang and Jinxi Zhao
    Citation: Cardiovascular Diabetology 2022 21:232
  23. Circulating thrombospondin-2 (TSP2) levels were associated with the development of heart failure (HF) in recent studies. However, these studies included only a minority of patients with type 2 diabetes, which ...

    Authors: CH Lee, MZ Wu, DTW Lui, CHY Fong, QW Ren, SY Yu, MMA Yuen, WS Chow, JY Huang, A Xu, KH Yiu and KSL Lam
    Citation: Cardiovascular Diabetology 2022 21:231
  24. Reduced lung function and adverse health outcomes are often observed. This study characterizes genetic susceptibility for reduced lung function and risk of developing a range of adverse health outcomes.

    Authors: Suneela Zaigham, Isabel Gonçalves, Regeneron Genetics Center, Gunnar Engström and Jiangming Sun
    Citation: Cardiovascular Diabetology 2022 21:230
  25. The relationship between triglyceride-glucose (TyG) index, an emerging marker of insulin resistance, and the risk of incident heart failure (HF) was unclear. This study thus aimed to investigate this relations...

    Authors: Xintao Li, Jeffrey Shi Kai Chan, Bo Guan, Shi Peng, Xiaoyu Wu, Xiaofeng Lu, Jiandong Zhou, Jeremy Man Ho Hui, Yan Hiu Athena Lee, Danish Iltaf Satti, Shek Long Tsang, Shouling Wu, Songwen Chen, Gary Tse and Shaowen Liu
    Citation: Cardiovascular Diabetology 2022 21:229
  26. Elevated remnant cholesterol (remnant-C) is considered a risk factor for cardiovascular disease (CVD); however, whether this notion applies to the East Asian population with type 2 diabetes (T2D) has not been ...

    Authors: Ji Hye Huh, Kyung-do Han, Yun Kyung Cho, Eun Roh, Jun Goo Kang, Seong Jin Lee and Sung-Hee Ihm
    Citation: Cardiovascular Diabetology 2022 21:228
  27. We aimed to investigate the gender difference in the association between changes in metabolic syndrome (MetS) and its components with the risk of cardiovascular disease (CVD) and coronary heart disease (CHD) a...

    Authors: Azra Ramezankhani, Fereidoun Azizi and Farzad Hadaegh
    Citation: Cardiovascular Diabetology 2022 21:227
  28. The triglyceride glucose (TyG) index, which is a new surrogate indicator of insulin resistance (IR), is thought to be associated with many diseases, such as cardiovascular disease, but its relationship with ce...

    Authors: Feifei Yan, Shoumeng Yan, Jing Wang, Yani Cui, Feinan Chen, Fang Fang and Weiwei Cui
    Citation: Cardiovascular Diabetology 2022 21:226
  29. Waist circumference (WC), visceral adiposity index (VAI), lipid accumulation product (LAP), and Chinese visceral adiposity index (CVAI) are considered surrogate indicators of abdominal fat deposition, but the ...

    Authors: Tingting Qiao, Tao Luo, Hualian Pei, Bahegu Yimingniyazi, Dilihumaer Aili, Aliya Aimudula, Hui Zhao, Huanwen Zhang, Jianghong Dai and Duolao Wang
    Citation: Cardiovascular Diabetology 2022 21:225
  30. Authors: Jinchun Wu, Tao Liu, Shaobo Shi, Zhixing Fan, Roddy Hiram, Feng Xiong, Bo Cui, Xiaoling Su, Rong Chang, Wei Zhang, Min Yan, Yanhong Tang, He Huang, Gang Wu and Congxin Huang
    Citation: Cardiovascular Diabetology 2022 21:224

    The original article was published in Cardiovascular Diabetology 2022 21:197

  31. Diabetes mellitus (DM) is associated with an increased mortality risk in patients hospitalized with acute myocardial infarction (AMI); however, no studies have investigated the impact of the duration of DM on ...

    Authors: Marta Baviera, Stefano Genovese, Pierluca Colacioppo, Nicola Cosentino, Andreana Foresta, Mauro Tettamanti, Ida Fortino, Maria Carla Roncaglioni and Giancarlo Marenzi
    Citation: Cardiovascular Diabetology 2022 21:223
  32. Coronary microvascular dysfunction (CMD) is common and is associated with unfavorable cardiovascular events in patients with diabetes mellitus (DM). Coronary angiography-derived index of microcirculatory resis...

    Authors: Wen Zhang, Shekhar Singh, Lu Liu, Abdul-Quddus Mohammed, Guoqing Yin, Siling Xu, Xian Lv, Tingting Shi, Cailin Feng, Rong Jiang, Ayman A. Mohammed, Redhwan M. Mareai, Yawei Xu, Xuejing Yu, Fuad A. Abdu and Wenliang Che
    Citation: Cardiovascular Diabetology 2022 21:222
  33. Previous studies showed that gestational diabetes mellitus (GDM) can be a risk factor for subsequent atherosclerotic cardiovascular disease. However, there is a paucity of information regarding diverse cardiov...

    Authors: Seung Mi Lee, Manu Shivakumar, Ji Won Park, Young Mi Jung, Eun Kyung Choe, Soo Heon Kwak, Sohee Oh, Joong Shin Park, Jong Kwan Jun, Dokyoon Kim and Jae-Seung Yun
    Citation: Cardiovascular Diabetology 2022 21:221
  34. Diabetes mellitus (DM) and cardiovascular diseases often co-exist. Today, percutaneous coronary intervention (PCI) is the preferred revascularization procedure for majority of patients with coronary artery dis...

    Authors: Hong Wang, Xiaoya Xie, Quannan Zu, Ming Lu, Rongfa Chen, Zhiren Yang and Yongqiang Gao
    Citation: Cardiovascular Diabetology 2022 21:220
  35. Authors: Jesus F. Garcia‑Gavilan, Margery A. Connelly, Nancy Babio, Christos S. Mantzoros, Emilio Ros and Jordi Salas‑Salvado
    Citation: Cardiovascular Diabetology 2022 21:219

    The original article was published in Cardiovascular Diabetology 2022 21:189

  36. Few studies have examined the association between hypoglycemic episodes among people with type 2 diabetes (T2DM) at the time of hospitalization for heart failure (HF) and cardiovascular outcomes.

    Authors: Seon-Ah Cha, Jae-Seung Yun, Gee-Hee Kim and Yu-Bae Ahn
    Citation: Cardiovascular Diabetology 2022 21:218
  37. Stress hyperglycemia is strongly associated with poor clinical outcomes in patients with acute coronary syndrome (ACS). Recently, the stress hyperglycemia ratio (SHR) has been proposed to represent relative hy...

    Authors: Wei Xu, Qirui Song, Xiang Wang, Zinan Zhao, Xuyang Meng, Chenxi Xia, Yibo Xie, Chenguang Yang, Ying Guo, Yatong Zhang and Fang Wang
    Citation: Cardiovascular Diabetology 2022 21:217
  38. It is not clear whether pre-existing macrovascular complications (ischemic heart disease, stroke or peripheral artery disease) are associated with health outcomes in people with diabetes mellitus hospitalized ...

    Authors: Gemma Llauradó, Bogdan Vlacho, Matthieu Wargny, Yue Ruan, Josep Franch-Nadal, Pere Domingo, Pierre Gourdy, Pierre-Jean Saulnier, Samy Hadjadj, Sarah H. Wild, Rustam Rea, Bertrand Cariou, Kamlesh Khunti and Dídac Mauricio
    Citation: Cardiovascular Diabetology 2022 21:216
  39. The triglyceride-glucose index (TyG) has been proposed as a surrogate marker of insulin resistance, which is a typical trait of pregnancy. However, very few studies analyzed TyG performance as marker of insuli...

    Authors: Benedetta Salvatori, Tina Linder, Daniel Eppel, Micaela Morettini, Laura Burattini, Christian Göbl and Andrea Tura
    Citation: Cardiovascular Diabetology 2022 21:215
  40. Peripheral arterial disease (PAD) is one of the most disabling cardiovascular complications of type 2 diabetes mellitus and is indeed associated with a high risk of cardiovascular and limb adverse events. High...

    Authors: Maria Margherita Rando, Federico Biscetti, Andrea Leonardo Cecchini, Elisabetta Nardella, Maria Anna Nicolazzi, Flavia Angelini, Roberto Iezzi, Luis H. Eraso, Paul J. Dimuzio, Dario Pitocco, Antonio Gasbarrini, Massimo Massetti and Andrea Flex
    Citation: Cardiovascular Diabetology 2022 21:214
  41. New biomarkers to identify cardiovascular disease (CVD) risk earlier in its course are needed to enable targeted approaches for primordial prevention. We evaluated whether intraindividual changes in blood meta...

    Authors: Daniel Gonzalez Izundegui, Patricia E. Miller, Ravi V. Shah, Clary B. Clish, Maura E. Walker, Gary F. Mitchell, Robert E. Gerszten, Martin G. Larson, Ramachandran S. Vasan and Matthew Nayor
    Citation: Cardiovascular Diabetology 2022 21:213
  42. Data are limited on whether several easily measured indices are independent predictors of type 2 diabetes mellitus (T2DM) in hypertensive patients. This study aimed to assess the association of hypertriglyceri...

    Authors: Hai Deng, Peng Hu, Huoxing Li, Huanning Zhou, Xiuyi Wu, Maohua Yuan, Xueru Duan, Miaochan Lao, Chuchu Wu, Murui Zheng, Xiang Qian Lao, Wenjing Zhao and Xudong Liu
    Citation: Cardiovascular Diabetology 2022 21:212

    The Correction to this article has been published in Cardiovascular Diabetology 2023 22:7

  43. Patients with type 2 diabetes mellitus (T2DM) are considered as a homogeneous cohort of patients. However, the specific role of diabetic microvascular complications (DMC), in determining the features of corona...

    Authors: Rocco A. Montone, Dario Pitocco, Filippo Luca Gurgoglione, Riccardo Rinaldi, Marco Giuseppe Del Buono, Massimiliano Camilli, Alessandro Rizzi, Linda Tartaglione, Gaetano Emanuele Rizzo, Mauro Di Leo, Andrea Flex, Michele Russo, Giovanna Liuzzo, Giulia Magnani, Riccardo C. Bonadonna, Diego Ardissino…
    Citation: Cardiovascular Diabetology 2022 21:211
  44. Non-obese non-alcoholic fatty liver disease (NAFLD) has been reported to share clinical outcomes with its obese counterpart in the general population. However, conflicting results have been observed regarding ...

    Authors: Ziyin Zhang, Lu Zhang, Wangyan Jiang, Tingting Du and Gang Yuan
    Citation: Cardiovascular Diabetology 2022 21:210
  45. Diagnosing fatty liver and identifying disease status are important for fatty liver related-diseases prevention. The fatty liver index (FLI), which can be easily available in clinical practice, can be very use...

    Authors: In-Ho Seo, Hye Sun Lee and Yong-Jae Lee
    Citation: Cardiovascular Diabetology 2022 21:209
  46. The modification of physical activity (PA) on the metabolic status in relation to atrial fibrillation (AF) in obesity remains unknown. We aimed to investigate the independent and joint associations of metaboli...

    Authors: Ruoting Wang, Ivan Olier, Sandra Ortega-Martorell, Yingxin Liu, Zebing Ye, Gregory YH Lip and Guowei Li
    Citation: Cardiovascular Diabetology 2022 21:208
  47. Compelling evidence suggests that the fibroblast growth factor 23 (FGF23) / α-klotho axis is impaired in subjects with diabetes mellitus. We examined the relationship between parameters related to calcium/phos...

    Authors: Esmeralda Castelblanco, Marta Hernández, Nuria Alonso, Aina Ribes-Betriu, Jordi Real, Minerva Granado-Casas, Joana Rossell, Marina Idalia Rojo-López, Adriana Silvia Dusso, Josep Julve and Didac Mauricio
    Citation: Cardiovascular Diabetology 2022 21:207
  48. Type 1 diabetes is associated with accelerated vascular aging and advanced atherosclerosis resulting in increased rates of cardiovascular disease and premature death. We evaluated associations between Leukocyt...

    Authors: Manuel Sanchez, Caroline Kannengiesser, Sophie Hoang, Louis Potier, Frédéric Fumeron, Nicolas Venteclef, André Scheen, Jean-François Gautier, Samy Hadjadj, Michel Marre, Ronan Roussel, Kamel Mohammedi and Gilberto Velho
    Citation: Cardiovascular Diabetology 2022 21:206
  49. Diabetic cardiomyopathy is characterized by left ventricle dysfunction, cardiomyocyte apoptosis, and interstitial fibrosis and is a serious complication of diabetes mellitus (DM). Autophagy is a mechanism that...

    Authors: Hongchao Wang, Lijie Wang, Fuli Hu, Pengfei Wang, Yanan Xie, Fang Li and Bingyan Guo
    Citation: Cardiovascular Diabetology 2022 21:205
  50. Insulin resistance is an important cause of cardiovascular events and cerebral infarction development. We aimed to investigate the association of the triglyceride glucose (TyG) index with atherosclerotic burde...

    Authors: Mengxing Wang, Lerong Mei, Aoming Jin, Xueli Cai, Jing Jing, Suying Wang, Xia Meng, Shan Li, Tiemin Wei, Yongjun Wang and Yuesong Pan
    Citation: Cardiovascular Diabetology 2022 21:204

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions